Erythrocyte a target for Covid-19 infected patients
Autor(a) principal: | |
---|---|
Data de Publicação: | 2020 |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | http://hdl.handle.net/10451/52902 |
Resumo: | Copyright@ Carlota Saldanha. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License, which permits unrestricted use and redistribution provided that the original author and source are credited. |
id |
RCAP_87a2985bc0e79a0d108948a84a9e9c1d |
---|---|
oai_identifier_str |
oai:repositorio.ul.pt:10451/52902 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Erythrocyte a target for Covid-19 infected patientsBlood smearsErythrocyte membrane band3 proteinNitric oxideMicrocirculationSystemic circulationCopyright@ Carlota Saldanha. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License, which permits unrestricted use and redistribution provided that the original author and source are credited.The questions about the Covid-2 and the discussion of the answers are the aim of the present opinion. Facing the great amount of knowledge centered in the field of red blood cells (RBC) or erythrocyte arise the principle for a diagnostic test with efficiency, accuracy, fast and cheap in order to differentiate the infected Covid-19 patients from those that are asymptomatic but with or without the Covid-19. Different results may be obtained and will be here discussed. The signal transduction mechanisms of nitric oxide in the RBC have key points that are therapeutic targets for compounds to apply in infected Covid-19 patients.Crimson PublishersRepositório da Universidade de LisboaSaldanha, Carlota2022-05-11T15:44:36Z20202020-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10451/52902engMod Appro Drug Des. 3(1). MADD. 000555. 2020.2576-917010.31031/MADD.2020.03.000555info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-11-08T16:58:21Zoai:repositorio.ul.pt:10451/52902Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T22:03:53.823387Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Erythrocyte a target for Covid-19 infected patients |
title |
Erythrocyte a target for Covid-19 infected patients |
spellingShingle |
Erythrocyte a target for Covid-19 infected patients Saldanha, Carlota Blood smears Erythrocyte membrane band3 protein Nitric oxide Microcirculation Systemic circulation |
title_short |
Erythrocyte a target for Covid-19 infected patients |
title_full |
Erythrocyte a target for Covid-19 infected patients |
title_fullStr |
Erythrocyte a target for Covid-19 infected patients |
title_full_unstemmed |
Erythrocyte a target for Covid-19 infected patients |
title_sort |
Erythrocyte a target for Covid-19 infected patients |
author |
Saldanha, Carlota |
author_facet |
Saldanha, Carlota |
author_role |
author |
dc.contributor.none.fl_str_mv |
Repositório da Universidade de Lisboa |
dc.contributor.author.fl_str_mv |
Saldanha, Carlota |
dc.subject.por.fl_str_mv |
Blood smears Erythrocyte membrane band3 protein Nitric oxide Microcirculation Systemic circulation |
topic |
Blood smears Erythrocyte membrane band3 protein Nitric oxide Microcirculation Systemic circulation |
description |
Copyright@ Carlota Saldanha. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License, which permits unrestricted use and redistribution provided that the original author and source are credited. |
publishDate |
2020 |
dc.date.none.fl_str_mv |
2020 2020-01-01T00:00:00Z 2022-05-11T15:44:36Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10451/52902 |
url |
http://hdl.handle.net/10451/52902 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
Mod Appro Drug Des. 3(1). MADD. 000555. 2020. 2576-9170 10.31031/MADD.2020.03.000555 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Crimson Publishers |
publisher.none.fl_str_mv |
Crimson Publishers |
dc.source.none.fl_str_mv |
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799134589563699200 |